What is it used for?
MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older. MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and pediatric patients 2 years and older.MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older. MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and pediatric patients 2 years and older.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- gemtuzumab ozogamicingemtuzumab ozogamicin
- Form and strength
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 5 mg / 5 mLINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 5 mg / 5 mL
- Manufacturer / applicant
- WYETH PHARMACEUTICALS LLC, A SUBSIDIARY OF PFIZER INC.WYETH PHARMACEUTICALS LLC, A SUBSIDIARY OF PFIZER INC.
For injection: 4.5 mg as a white to off-white lyophilized cake or powder in a single-dose vial for reconstitution and further dilution.For injection: 4.5 mg as a white to off-white lyophilized cake or powder in a single-dose vial for reconstitution and further dilution.
Safety and clinical review
Hepatotoxicity, including severe or fatal hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), has been reported in association with the use of MYLOTARG as a single agent, and as part of a combination chemotherapy regimen. Monitor frequently for signs …Hepatotoxicity, including severe or fatal hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), has been reported in association with the use of MYLOTARG as a single agent, and as part of a combination chemotherapy regimen. Monitor frequently for signs …
- Hepatotoxicity, Including Veno-occlusive Liver Disease (VOD)Hepatotoxicity, Including Veno-occlusive Liver Disease (VOD)
- Infusion-Related Reactions (Including Anaphylaxis)Infusion-Related Reactions (Including Anaphylaxis)
- HemorrhageHemorrhage
- QT Interval ProlongationQT Interval Prolongation
- Use in AML with Adverse-Risk CytogeneticsUse in AML with Adverse-Risk Cytogenetics
- Embryo-Fetal ToxicityEmbryo-Fetal Toxicity
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is MYLOTARG used for?
MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older. MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and pediatric patients 2 years and older.MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older. MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and pediatric patients 2 years and older.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of MYLOTARG should I ask about?
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 5 mg / 5 mLINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 5 mg / 5 mL
Read the primary sourceWhat determines the price of MYLOTARG?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using MYLOTARG?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.